LivaNova participated in a series A round for Shiratronics that will fund the progression of its migraine headache treatment device toward clinical testing.

Shiratronics, a US-based startup developing a migraine headache-treatment system, has closed a $33m series A round that included medical device producer LivaNova. Venture capital firms US Venture Partners (USVP) and Strategic HealthCare Investment Partners (SHIP) co-led the round with Amzak Health, a vehicle for asset manager Amzak Capital Management, while Aperture Venture Partners and an…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.